Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

New Market Study Published: Achillion Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report


Print article Print article
2013-12-26 00:01:55 - Fast Market Research recommends "Achillion Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report" from MarketLine, now available

Achillion Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Achillion Pharmaceuticals, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Achillion Pharmaceuticals, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Achillion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Achillion Pharmaceuticals, Inc.
* Intelligence on Achillion Pharmaceuticals, Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Achillion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/757322_achillion_pharmaceuticals_inc_swot_st ..

Highlights:

Achillion Pharmaceuticals (Achillion or 'the company') is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of infectious diseases such as chronic hepatitis C virus (HCV) and resistant bacterial infections. The company operates in the US where it is headquartered in New Haven, Connecticut. Achillion had 56 full-time employees and one part-time employee as of February 11, 2013. The company recorded revenues of $2.6 million during the financial year ended December 2012 (FY2012), an increase of 5.5% over FY2011. The operating loss of the company was $47.3 million in FY2012, as compared to an operating loss of $44.3 million over FY2011. The net loss was $47.1 million in FY2012, as compared to a net loss of $44.2 million over FY2011.

Reasons to Purchase:

* Gain understanding of Achillion Pharmaceuticals, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Achillion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Achillion Pharmaceuticals, Inc.'s business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Achillion Pharmaceuticals, Inc.: Company Overview
Achillion Pharmaceuticals, Inc.: Overview and Key Facts
Achillion Pharmaceuticals, Inc.: Overview
Achillion Pharmaceuticals, Inc.: Key Facts
Achillion Pharmaceuticals, Inc.: Key Employees
Achillion Pharmaceuticals, Inc.: Key Employee Biographies
Achillion Pharmaceuticals, Inc.: Major Products and Services
Achillion Pharmaceuticals, Inc.: Company History
Achillion Pharmaceuticals, Inc.: Management Statement
Achillion Pharmaceuticals, Inc.: Locations and Subsidiaries
Achillion Pharmaceuticals, Inc.: Key Competitors
Achillion Pharmaceuticals, Inc.: Company Analysis
Achillion Pharmaceuticals, Inc.: Business Description
Achillion Pharmaceuticals, Inc.: SWOT Analysis
Achillion Pharmaceuticals, Inc.: SWOT Overview
Achillion Pharmaceuticals, Inc.: Strengths
Achillion Pharmaceuticals, Inc.: Weaknesses
Achillion Pharmaceuticals, Inc.: Opportunities
Achillion Pharmaceuticals, Inc.: Threats
Achillion Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Achillion Pharmaceuticals, Inc.: Financial Deals Overview
Achillion Pharmaceuticals, Inc.: Targets and Partners
Achillion Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Achillion Pharmaceuticals, Inc.: Advisors
Achillion Pharmaceuticals, Inc.: Top Financial Advisors
Achillion Pharmaceuticals, Inc.: Capital Raising
Achillion Pharmaceuticals, Inc.: Partnership
Achillion Pharmaceuticals, Inc.: Private Equity and Ownership
Achillion Pharmaceuticals, Inc.: Recent Developments
Achillion Pharmaceuticals, Inc.: News and Events Summary
Achillion Pharmaceuticals, Inc.: Business Expansion
Achillion Pharmaceuticals, Inc.: Contracts
Achillion Pharmaceuticals, Inc.: Corporate Governance
Achillion Pharmaceuticals, Inc.: Financial Deals
Achillion Pharmaceuticals, Inc.: Financial Performance
Achillion Pharmaceuticals, Inc.: Grants
Achillion Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Achillion Pharmaceuticals, Inc.: Key Facts
Table 2: Achillion Pharmaceuticals, Inc.: Key Employees
Table 4: Achillion Pharmaceuticals, Inc.: Key Competitors
Table 5: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 7: Achillion Pharmaceuticals, Inc.: Targets and Partners
Table 8: Achillion Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Table 9: Achillion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: Achillion Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 11: Achillion Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 12: Achillion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 13: Achillion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 14: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2009 - YTD*2013)
Table 15: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2009 - YTD*2013)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=757322&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com